Suzhou Ribo Life Science Co., Ltd. (HKG:6938)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
64.70
+0.35 (0.54%)
At close: Apr 2, 2026

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '19 Dec '18 Dec '17
Biotechnology (Startups)
148.51M142.63M44.00K--
Biotechnology (Startups) Growth
4.12%324052.27%---
Total
148.51M142.63M44.00K--
Total Growth
4.12%324052.27%---

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2019FY 2018FY 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '19 Dec '18 Dec '17
Overseas
105.41M101.05M---
Overseas Growth
4.31%----
Mainland China
43.10M41.58M44.00K--
Mainland China Growth
3.67%94393.18%---
Total
148.51M142.63M44.00K--
Total Growth
4.12%324052.27%---
Source: S&P Global Market Intelligence.